Screening of specific binding peptide targeting blood vessel of human esophageal cancer in vivo in mice

Chinese Medical Journal

Volumn 124, Issue 4, 2011, Pages 581-585

  Zhi, Min ^a   Wu, Kai Chun ^b   Hao, Zhi Ming ^c   Guo, Chang Cun ^b   Yao, Jia Yin ^a  

^a THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Esophageal cancer; In vivo; Peptide

Indexed keywords

LEUCYLPROLYLALANYLMETHIONYLPROLYLASPARAGINYLSERINE; PEPTIDE DERIVATIVE; PROLYLASPARAGINYLPROLYLASPARAGINYLASPARAGINYLSERYLTHREONINE; PROLYLMETHIONYLASPARAGINYLALANYLASPARTYLASPARAGINYLLEUCINE; SERYLARGINYLHISTIDINYLASPARTYLLEUCYLASPARAGINYLSERINE; SERYLPROLYLALANYLASPARAGINYLLEUCYLGLUTAMYLTHREONINE; SERYLTHREONYLVALYLALANYLTHREONYLSERYLGLUTAMINE; TYROSYLPROLYLTHREONYLPROLYLTYROSYLASPARTYLISOLEUCINE; TYROSYLSERYLISOLEUCYLASPARAGINYLASPARTYLTRYPTOPHANYLHISTIDINE; TYROSYLSERYLPHENYLALANYLASPARAGINYLSERYLTRYPTOPHANYLMETHIONINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; ESOPHAGUS CANCER; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LUNG; MOUSE; NONHUMAN; PHAGE DISPLAY; SPLEEN; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; ENDOTHELIAL CELLS; ESOPHAGEAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; PEPTIDE LIBRARY; PEPTIDES;

EID: 79951799258     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.04.018     Document Type: Article

References (31)

1. Wang Z, Liu XY, Liu FY, Chen JH. Lymph node micrometastasis in patients with esophageal cancer: diagnosis and a prospective study of impact on prognosis. World Chin J Digest (Chin) 2004; 12: 121-124.
2. He YT, Hou J, Qiao CY, Chen ZF, Song GH, Li SS, et al. An analysis of esophageal cancer incidence in Cixian country from 1974 to 1996. World J Gastroenterol 2003; 9: 209-213.
3. Wang GQ, Liu YY, Hao CQ, Lai SQ, Wang GQ, Lu N, et al. A comparative study of endoscopic image stained by iodine and histopathology in early esophageal cancer and precancerous lesions (dysplasia). Chin J Oncol (Chin) 2004; 26: 342-344.
4. Qi FY, Zhang LX, Han CL, Zuo LF, Lin PZ, Guo JW. Up-regulation of cyclooxygenase-2 in carcinogenesis of esophageal epithelia. World Chin J Digest (Chin) 2003; 11: 508-511.
5. Qin HY, Shu Q, Wang D, Ma QF. Study on genetic polymorphisms of DCC gene VNTR in esophageal cancer. World Chin J Digest (Chin) 2000; 8: 782-785.
6. Barbour AP, Lagergren P, Hughes R, Alderson D, Barham CP, Blazeby JM. Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. Br J Surg 2008; 95: 80-84.
7. Crumley AB, McMillan DC, McKernan M, Going JJ, Shearer CJ, Stuart RC. An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer 2006; 94: 1568-1571.
8. Quera R, O'Sullivan K, Quigley EM. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma? Endoscopy 2006; 38: 162-169.
9. Zhi M, Wu KC, Dong L, Hao ZM, Deng TZ, Hong L, et al. Characterization of a specific phage-displayed peptide binding to vasculature of human gastric cancer. Cancer Biol Ther 2004; 3: 1232-1235.
10. Liang S, Lin T, Ding J, Pan Y, Dang D, Guo C, et al. Screening and identification of vascular-endothelialcell- specific binding peptide in gastric cancer. J Mol Med 2006; 84: 764-773.
11. Bai F, Liang J, Wang J, Shi Y, Zhang K, Liang S, et al. Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer. J Mol Med 2007; 85: 169-180.
12. Siemann DW, Chaplin DJ, Horsman MR.Vascular-targeting therapies for treatment of malignant disease. Cancer 2004; 100: 2491-2499.
13. Taraboletti G, Giavazzi R. Modelling approaches for angiogenesis. Eur J Cancer 2004; 40: 881-889.
14. Folkman J. Angiogenesis and apoptosis. Semin Cancer Biol 2003; 13: 159-167.
15. Kotz JD, Bond CJ, Cochran AG. Phage-display as a tool for quantifying protein stability determinants. Eur J Biochem 2004; 271: 1623-1629.
16. Romanov VI. Phage display selection and evaluation of cancer drug targets. Curr Cancer Drug Targets 2003; 3: 119-129.
17. Rutledge SE, Volkman HM, Schepartz A. Molecular recognition of protein surfaces: high affinity ligands for the CBP KIX domain. J Am Chem Soc 2003; 125: 14336-14347.
18. Tayapiwatana C, Arooncharus P, Kasinrerk W. Displaying and epitope mapping of CD147 on VCSM13 phages: influence of Escherichia coli strains. J Immunol Methods 2003; 281: 177-185.
19. Sidhu SS, Fairbrother WJ, Deshayes K. Exploring protein-protein interactions with phage display. Chembiochem 2003; 4: 14-25.
20. Christianson DR, Ozawa MG, Pasqualini R, Arap W. Techniques to decipher molecular diversity by phage display. Methods Mol Biol 2007; 357: 385-406.
21. Sergeeva A, Kolonin MG, Molldrem JJ, Pasqualini R, Arap W. Display technologies: application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev 2006; 58: 1622-1654.
22. Kzhyshkowska J, Workman G, Cardo-Vila M, Arap W, Pasqualini R, Gratchev A, et al. Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC. J Immunol 2006; 176: 5825-5832.
23. Kolonin MG, Sun J, Do KA, Vidal CI, Ji Y, Baggerly KA, et al. Synchronous selection of homing peptides for multiple tissues by in vivo phage display. FASEB J 2006; 20: 979-981.
24. Han ZY, Wu KC, He FT, Han QL, Nie YZ, Han Y, et al. Screening and identification of mimotope of gastric cancer associated antigen MGb1-Ag. World J Gastroenterol 2003; 9: 1920-1924.
25. Bunn HF. New agents that stimulate erythropoiesis. Blood 2007; 109: 868-873.
26. Wang P, Ding J, Lin T, Han S, Cao SS, Ge FL, et al. MDR-reversing effect of short peptide binding specifically to multidrug-resistant gastric cancer cells. Chin J Oncol (Chin) 2007; 29: 258-261.
27. Sola A, Rogido M, Lee BH, Genetta T, Wen TC. Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats. Pediatr Res 2005; 57: 481-487.
28. Takagi J. Structural basis for ligand recognition by RGD (Arg-Gly-Asp)-dependent integrins. Biochem Soc Trans 2004; 32: 403-406.
29. Kolachala VL, Bajaj R, Wang L, Yan Y, Ritzenthaler JD, Gewirtz AT, et al. Epithelial-derived fibronectin: expression, signaling and function in intestinal inflammation. J Biol Chem 2007; 282: 32965-32973.
30. Cody V, Davis PJ, Davis FB. Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin. Steroids 2007; 72: 165-170.
31. Majhen D, Gabrilovac J, Eloit M, Richardson J, Ambriovic-Ristov A. Disulfide bond formation in NGR fiber-modified adenovirus is essential for retargeting to aminopeptidase N. Biochem Biophys Res Commun 2006; 348: 278-287.